276 related articles for article (PubMed ID: 24070502)
1. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.
Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A
J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
3. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
[TBL] [Abstract][Full Text] [Related]
4. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
8. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
[TBL] [Abstract][Full Text] [Related]
9. Colistin-resistant carbapenemase-producing isolates among Klebsiella spp. and Acinetobacter baumannii in Tripoli, Libya.
Kieffer N; Ahmed MO; Elramalli AK; Daw MA; Poirel L; Álvarez R; Nordmann P
J Glob Antimicrob Resist; 2018 Jun; 13():37-39. PubMed ID: 29530497
[No Abstract] [Full Text] [Related]
10. In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.
Wei W; Yang H; Liu Y; Ye Y; Li J
J Chemother; 2016 Jun; 28(3):159-63. PubMed ID: 25978105
[TBL] [Abstract][Full Text] [Related]
11. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
[No Abstract] [Full Text] [Related]
13. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant
Ayerbe-Algaba R; Gil-Marqués ML; Jiménez-Mejías ME; Sánchez-Encinales V; Parra-Millán R; Pachón-Ibáñez ME; Pachón J; Smani Y
Front Cell Infect Microbiol; 2018; 8():348. PubMed ID: 30338245
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
[TBL] [Abstract][Full Text] [Related]
15. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
[TBL] [Abstract][Full Text] [Related]
17. Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.
Nordqvist H; Nilsson LE; Claesson C
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1845-1850. PubMed ID: 27510182
[TBL] [Abstract][Full Text] [Related]
18. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.
Jernigan MG; Press EG; Nguyen MH; Clancy CJ; Shields RK
Antimicrob Agents Chemother; 2012 Jun; 56(6):3395-8. PubMed ID: 22430958
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.
Richter SE; Miller L; Uslan DZ; Bell D; Watson K; Humphries R; McKinnell JA
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976595
[TBL] [Abstract][Full Text] [Related]
20. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
